Dynamics of T Cell Receptor Distributions Following Acute Thymic Atrophy
  and Resumption by Lewkiewicz, Stephanie M. et al.
ar
X
iv
:1
90
5.
12
17
9v
1 
 [q
-b
io.
PE
]  
29
 M
ay
 20
19
Dynamics of T Cell Receptor Distributions Following Acute Thymic
Atrophy and Resumption
Stephanie M. Lewkiewicz1, Yao-Li Chuang2, and Tom Chou∗3
1,3Department of Mathematics, UCLA, Los Angeles, CA, 90095-1555, USA
2Department of Mathematics, CalState Northridge, Northridge, CA 91330, USA
3Department of Biomathematics, UCLA, Los Angeles, CA, 90095-1766, USA
May 30, 2019
Abstract
Naive human T cells are produced in the thymus, which atrophies abruptly and severely in response to physical or
psychological stress. To understand how an instance of stress affects the size and “diversity” of the peripheral naive
T cell pool, we derive a mean-field autonomous ODE model of T cell replenishment that allows us to track the clone
abundance distribution (the mean number of different TCRs each represented by a specific number of cells). We
identify equilibrium solutions that arise at different rates of T cell production, and derive analytic approximations
to the dominant eigenvalues and eigenvectors of the problem linearized about these equilibria. From the forms of the
eigenvalues and eigenvectors, we estimate rates at which counts of clones of different sizes converge to and depart
from equilibrium values–that is, how the number of clones of different sizes “adjust” to the changing rate of T cell
production. Under most physiologically realistic realizations of our model, the dominant eigenvalue (representing
the slowest dynamics of the clone abundance distribution) scales as a power law in the thymic output for low
output levels, but saturates at higher T cell production rates. Our analysis provides a framework for quantitatively
understanding how the clone abundance distributions evolve under small changes in the overall T cell production
rate by the thymus.
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1 Introduction
The thymus, a small organ located above the heart in humans, is a crucial component of the primary lymphoid
architecture, as the site of T cell development [1, 2]. The many different T cell subpopulations together guide and
assist the action of other immune agents during infection [3], regulate the immune response [4], and retain memory
of encountered pathogens [5]. As such, the thymus supplies the immune compartment with its most essential source
of direction, support, and regulation. T cells are produced when lymphocyte progenitors derived from hematopoietic
stem cells in the bone marrow migrate to the thymus and begin a process of role selection, maturation, and vetting,
before being exported to the peripheral blood [6]. The most significant event during thymocyte development is the
rearrangement of the α and β chains of the T cell receptor (TCR) [7] that occurs in the thymic cortex which is populated
with thymocyte progenitors. The particular rearrangement a T cell undergoes determines its antigen specificity; a
naive T cell in the peripheral pool is activated when its TCR is bound by a cognate antigen, a pathogen-derived
peptide fragment capable of stimulating that particular TCR [8]. The total number of distinct TCRs present across
the full T cell pool is the “TCR diversity” [9], and this quantifies the breadth of the pool’s antigen responsiveness [10].
Thymocytes also undergo negative selection to eliminate cells that react too strongly to self antigens presented by
resident macrophages and dendritic cells. The small number of T cells that survive this process are functionally
competent and thus exported to the peripheral blood to participate in the immune mechanism.
The thymus is known to experience both chronic and acute forms of atrophy [11], resulting from both normal
biological processes and the presence of disease or stress. The most universal form of thymic atrophy is age-related
involution, the process by which productive thymic tissue is gradually replaced with nonproductive fat [12]. Involution
begins at puberty and continues indefinitely, and the resulting decline in T cell production has been implicated as a likely
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source of immune dysfunction in the elderly [13–15]. Acute atrophy can occur under a plethora of conditions associated
with a state of disease or stress [16–18], including viral, bacterial, and fungal infection [19–21], malnutrition [22], cancer
treatment [23], bone marrow transplant [24], psychological stress, and pregnancy [25–27]. Each condition facilitates
thymic atrophy in (at least) one of several ways, including reducing thymic cellularity [11], decreasing thymocyte
proliferation and increasing apoptosis [28], instigating premature export of underdeveloped thymocytes [29], and
inducing morphological changes to the thymic microenvironment [30]. Such disturbances may consequently alter the
size and composition of the peripheral T cell pool. Decreased lymphocyte prevalence in the periphery during acute
involution has been documented [31–34], and Salmonella, which infects the thymus itself, has been shown to disrupt
positive and negative selection, producing a skewed TCR repertoire [35]. Radiation and chemotherapy drugs, such
as temozolmide, used to treat cancer can also be highly lymphotoxic, producing a lymphopenic state referred to as
“treatment-related lymphopenia” (TRL) [36–38]. Viral infections, particularly HIV, and autoimmune disorders can
induce lymphopenia by increasing peripheral cellular death and redistributing cells to inappropriate tissues, in addition
to affecting production in the thymus [39]. Congenital thymic aplasia, as seen in complete DiGeorge syndrome, results
in a lymphopenic state at birth [40].
The activation of the hypothalamic-pituitary-adrenal axis by stress stimuli and subsequent release of glucocorticoids,
which are known to induce apoptosis in double-positive thymocytes [41] and inhibit their differentiation [28], is also
likely a major underlying catalyst of this acute involution [17, 42]. Evidence suggests that glucocorticoid release is
actually necessary to affect thymic atrophy [18,28]. Several other chemical agents have been observed to participate in
thymic atrophy, notably sex hormones [17], which have been shown to weaken thymocyte proliferation [25] and induce
apoptosis [43], and the IL-6 cytokine family, which is demonstrably thymosuppressive [16]. Despite this apparent
sensitivity to stress, the thymus is highly plastic, and generally recovers in size and functionality after removal of the
stressor [11]. Studies of the thymus during and after chemotherapy treatment in cancer patients indicate a return of
thymic volume and productivity during recovery from treatment [23]. A recuperating thymus may even surpass its
pre-treatment volume, in a phenomenon known as “thymic rebound” [44,45]. Such thymic recovery has also been seen
after infection [46] and traumatic injury [47]. However, recovery is demonstrably age-dependent, with thymi of older
patients reconstituting the naive T cell compartment more weakly than those of younger patients [23]. Although acute
thymic atrophy has been observed extensively in humans, much has yet to be learned about it, and clear treatment
protocol is lacking [11].
To this end, we present a mechanistic mathematical model to predict changes in the size and diversity of the
peripheral naive T cell compartment in response to various immunologically diseased conditions. We study how this
pool’s size and composition adjust to changes in the rate of thymic output. We compartmentalize the peripheral T
cell pool by grouping clones–collections of T cells with the same TCR–according to their size. We then use a high-
dimensional autonomous ODE system to follow the time evolution of the number of clones in each compartment. We
assume that the size of the peripheral naive T cell pool is dictated by rates of thymic export of new T cells, along
with homeostatic proliferation and death mechanisms. We assume a piecewise constant rate of thymic export, as the
atrophy/recovery cycle is known to be a rapid process, and that the proliferative and death processes are subject
to homeostatic regulation based on the total T cell pool size. We derive analytic approximations to the dominant
eigenvalues and eigenvectors of the system linearized around its equilibria in both the presence and the absence of
thymic activity. From this, we assess the rates of convergence of different T cell compartments to equilibria that result
from a changing thymic export rate. We then compare the linearized and fully nonlinear models, and study several
special cases. We also compute explicit representations of solutions in an infinite-dimensional extension of our model.
2 Mathematical Model and Analysis
We assume that the total naive T cell population N(t) in the immune compartment (the blood and lymphatic tissue)
satisfies a general ODE of the form
dN
dt
= γ + p(N)N − µ(N)N, (1)
where γ ≥ 0 is the rate of naive T cell export from the thymus, and p(N), µ(N) ≥ 0 are regulated, N -dependent rates
of proliferation and death of naive T cells in the peripheral bloodstream. To prevent unbounded growth, we take p(N)
to be non-increasing and µ(N) to be non-decreasing as cell counts, N , increase. We assume that p(0) > µ(0), as the
lymphopenic proliferation rate would be higher than the lymphopenic death rate [48–51]. At steady-state, when a
healthy, homeostatic cell count N∗ is achieved, p(N∗)− µ(N∗) = − γ
N∗
≤ 0. Note that when γ = 0, simple decreasing
functions p(N) (and/or increasing functions µ(N)) admit multiple–typically two–fixed points. The N = 0 fixed point
is unstable, while the one at N > 0 is stable.
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In order to compute the peripheral naive T cell diversity, we couple Eq. 1 with a system of ODEs that describes
the time evolution of the size-segregated subpopulations of the peripheral naive T cell pool. Let ck(t) denote the
number of clones that are of size k at time t ≥ 0. As formally shown in Song & Chou [52], the mean clone count is
ck ∝ P (ni = k, t), the marginalized probability that any single clone i has population k. The master equation for
P (ni, t) is difficult to solve with regulation terms. Here, we provide a heuristic derivation of the equations obeyed by
ck(t) by using a mean-field approximation that the total population N is uncorrelated with any ni (although we know
N =
∑∞
i=1 ni). Under this mean-field approximation, the evolution of P (ni = k, t) and hence ck(t) obeys
dc1
dt
=
γ
Ω
[
Ω−
M∑
i=1
ci − c1
]
− p(N)c1 + µ(N) [2c2 − c1] , (2)
dck
dt
=
γ
Ω
[ck−1 − ck] + p(N) [(k − 1)ck−1 − kck] + µ(N) [(k + 1)ck+1 − kck] , (3)
dcM
dt
=
γ
Ω
cM−1 + p(N)(M − 1)cM−1 − µ(N)McM , (4)
where k = 2, 3, · · · ,M − 1, p(N) and µ(N) are approximated by p(N(t)) and µ(N(t)) (where N(t) is the solution
to Eq. 1), and the index M in Eq. 4 is the hypothetical maximum size a clone can achieve. We take M to be finite
for mathematical tractability and in accordance with evidence of intraclonal competition that restricts clone sizes and
preserves a balanced TCR diversity [53]. Each of the ODEs in Eqs. 2–4 describes how ck changes due to the effects
of thymic export of new cells, and proliferation and death in the periphery. The constant Ω denotes the large total
number of clonotypes that can potentially be assembled in and exported from the thymus. The basic model includes
immigration, birth, and death of multiple species (i.e., clones) and can be developed in a fully stochastic setting;
however, in that case, only steady-state solutions are available [54].
In Eq. 3, the term γΩ represents the rate at which cells of a given clonotype are exported to the periphery from
the thymus, and thus γΩck represents the export rate of cells of clonotypes already represented by size-k clones in the
periphery. The addition of a new cell to a clone of population k decreases by one the number of clones with population
k and increases by one the number of clones with population k+1. Similarly, γΩck−1 represents the rate at which clones
move from ck−1 to ck due to thymic export. We assume that cells immigrate, proliferate, or die one cell at a time, forcing
clones to move only among adjacent compartments. Thus, the term γΩ [ck−1 − ck] fully accounts for changes to ck due to
thymic export. The term p(N)kck denotes the rate at which cells in size-k clones proliferate, which in turn corresponds
to the rate at which clones move from ck to ck+1 due to peripheral proliferation. Analogously, p(N)(k−1)ck−1 denotes
the rate at which clones enter ck from ck−1 due to proliferation, so that p(N) [(k − 1)ck−1 − kck] accounts for changes
to ck due to proliferation. The death term in Eq. 3, given by µ(N) [(k + 1)ck+1 − kck] is defined analogously. In Eqs. 2
and 4, we modify Eq. 3 to account for appropriate “boundary conditions.” In Eq. 2, the term
[
Ω−
∑M
i=1 ci
]
gives the
number of clonotypes unrepresented in the periphery, so that γΩ
[
Ω−
∑M
i=1 ci
]
provides the rate at which new clones
enter the periphery from the thymus. Eq. 2 also retains the terms from Eq. 3 that account for loss of clones in c1 due
to thymic export, proliferation, and death, and the addition of clones into c1 due to death of cells in c2. Finally, Eq. 4
retains terms accounting for the introduction of clones into cM via thymic export to and proliferation within clones in
cM−1, as well as loss of clones from cM due to cellular death. This represents a “boundary condition” that prevents
clones from surpassing size M .
Summing Eqs. 2-4, we find that
d
(∑M
k=1 kck
)
dt
= γ + p(N)
(
M∑
k=1
kck
)
− µ(N)
(
M∑
k=1
kck
)
−
(
p(N)McM +
γ0
Ω
cM
)
, (5)
so that the ODE satisfied by N(t) (Eq. 1) and that satisfied by
∑M
k=1 kck(t) (Eq. 5) differ by
(
p(N)McM +
γ0
Ω cM
)
,
and thus N(t) 6=
∑M
k=1 kck. Thus, very few numbers of clones of large sizes k > M , whose population is accounted
for in Eq. 1, are not accounted for fully in Eqs. 2–4. This is especially salient in the γ = 0 limit in which the N > 0
fixed point is completely “missed” by the ck = 0 solution to Eqs. 2–4. Thus, the γ → 0
+ limit of the truncated system
represents a singular limit where the only solution to Eqs. 2–4, ck → 0
+, appears to violate the N =
∑∞
k=1 kck > 0
constraint at the stable fixed point.
Nonetheless, we can use the ODE system Eqs. 2–4 to analyze the effects of changes in the thymic output rate γ
provided we carefully use the solutions of ck and N that are consistent with the N = 0 and N > 0 fixed points. We
denote the normal level of thymic export in an adult of a given age by γ = γ0. To represent diminished thymic activity
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during atrophy, we take γ ≪ γ0, or even γ = 0, depending on the severity of the atrophy. As the thymus is highly
plastic, the changes in γ throughout the process of atrophy and recovery tend to be rapid. With this in mind, we model
such cycles of disease with a piecewise ODE system. Specifically, let us observe a human’s response to disease-induced
changes in thymic activity over some time interval I = [t0, tS+1]. We assume that this individual’s thymic export rate
undergoes S abrupt changes, at times t1, t2, · · · , tS , where t0 < t1 < t2 < . . . < tS < tS+1. Letting Ii = [ti, ti+1], so
that I =
⋃S
i=0 Ii, we assume that γ = γi ≥ 0, on Ii. If the initial condition {ck(t0)}
M
k=1 represents the size of each
ck compartment at the start of the process, we then let {c
i
k(t)}
M
k=1 represent the solution of the ODE in Eqs. 1-4, on
Ii, with γ = γi and initial condition {c
i
k(ti)}
M
k=1 = {c
i−1
k (ti)}
M
k=1, for i = 1, 2, · · · , S. Thus, the solution {c
i
k(t)}
M
k=1
represents the time evolution of the ck compartments after a transition to a thymic activity level γi. This is the most
general description of our model; in practice, we will typically take S = 1, representing a single abrupt change in
γ(t). Further descriptions of the piecewise ODE formulation specific to certain disease patterns and particular initial
conditions are included in the relevant sections below.
Linear analysis of Eqs. 2–4 will provide information on how the clone counts ck(t) evolve from their steady-state
values after a small perturbation in the system (through changes in γ). The dynamics of ck are not equivalent, but are
qualitatively related to those of ni(t), the number of cells in clone i. For example, when large values of ni(t) increase,
ck≈ni(t) decreases while ck≈ni+1 increases. Thus, increases in large ni convects ck forward, especially for larger k.
As will be explicitly shown, since ck is typically monotonically decreasing in k, the dynamics of small(large) clone
populations are correlated with the dynamics of ck for small(large) k.
3 Analysis for γ > 0 (functioning thymus)
We begin by studying the behavior of solutions of our ODE model under the assumption of a strictly positive thymic
export rate, γ > 0. We perform an analysis of equilibrium solutions of Eqs. 1-4 and their stability, and also compute
an explicit solution in the infinite dimensional case that arises when M → ∞. At the beginning of sections 3.1
and 3.2 below, as well as in sections 4.1, 4.2, and 5, we focus on solutions over one individual interval in the piecewise
formulation described in section 2 above. For simplicity when doing this, we omit the i notation that distinguishes
the different subintervals, writing γ instead of γi, etc. When the discussion returns to the full piecewise ODE, the i
notation is reintroduced.
3.1 Analytic Solution of the Infinite Dimensional System
We begin by computing analytic expressions for the solutions ck of Eqs. 1-4. If we take M →∞ and consider instead
the infinite dimensional system, the ck compartments can be obtained through a generating function in a conjugate
variable q, defined as
Q(q, t) ≡
∞∑
k=0
ck(t)q
k, (6)
Note that ∂kQ/∂qk
∣∣
q=0
= k!ck allows us to extract ck with k ≥ 0. In addition, the total population can also be
recovered from the generating function via ∂Q/∂q|q=1 =
∑∞
k=0 kck = N .
In order to derive an explicit form for Q(q, t), we assume that an explicit solution N = N(t) of Eq. 1 can be found,
so that we may write p and µ as functions of t (p = p(t), µ = µ(t)). By substituting Eqs. 2, 3 for dck/dt, the time
derivative of Q can be expressed as
∂Q
∂t
=
∞∑
k=0
dck
dt
qk = (q − 1)(p(t)q − µ(t))
∂Q
∂q
+
γ
Ω
(q − 1)Q. (7)
The above partial differential equation can be solved analytically along any characteristic curve q(t) defined by the
solutions to dqdt = −(q − 1)(p(t)q − µ(t)):
q(t) = 1 +
(1 − q0)A(t)
(1 − q0)B(t)− 1
, (8)
where q0 = q(0) and
A(t) ≡ exp
(
−
∫ t
0
(p(s)− µ(s)) ds
)
and B(t) ≡
∫ t
0
p(s)A(s)ds. (9)
Along each trajectory q(t), the generating function obeys dQdt = −
γ(t)
Ω (1− q(t))Q and can be expressed as
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Q(q(t), t) =
∞∑
k=0
ck(0)q
k
0 exp
(
−
∫ t
0
γ(s)
Ω
(1− q(s))ds
)
. (10)
By allowing all possible initial values q0, we can express the full solution as
Q(q, t) =
∞∑
k=0
ck(0)
[
1−
1− q
(1− q)B(t) +A(t)
]k
exp
[
−
∫ t
0
ds
γ(s)
Ω
(1− q)A(s)
(1− q)(B(t) −B(s)) +A(t)
]
. (11)
The solutions of ck(t) can then be extracted from Q(q, t) by taking a power expansion of Q(q, t) and identifying
coefficients with ck(t) according to Eq. 6. These exact solutions to ck(t) will be compared with our subsequent results
derived from direct numerical solution of Eqs. 1–4. By verifying that the time evolution of ck under a finite dimensional
formulation as in Eqs. 2–4 is sufficiently close to that of ck under the infinite dimensional formulation in Eq. 11, we allow
the infinite and finite dimensional systems to be used more or less interchangeably. The finite dimensional formulation
has the advantage of not only admitting simple, explicit steady state solutions, but also rates of convergence to steady
state.
3.2 Equilibrium Solution and Linearization
Returning to the truncated formulation (finite M), we now study the equilibrium solution that results when taking
γ > 0 in Eqs. 1-4. Denote such a generic equilibrium solution by {c∗k(γ)}
M
k=1, N
∗(γ). For a given N∗(γ), the c∗k(γ)
have the form
c∗1(γ) = γ

 M∑
i=1
γ/Ω
i!µ(N∗(γ))i−1

i−1∏
j=1
[ γ
Ω
+ jp(N∗(γ))
]+ µ(N∗(γ))


−1
, (12)
c∗k(γ) =
c∗1(γ)
k!µ(N∗(γ))k−1
k−1∏
n=1
[ γ
Ω
+ np(N∗(γ))
]
. (13)
In the discussion below, we will write N∗(γ) as N∗ and c∗k(γ) as c
∗
k for simplicity, unless desiring to emphasize
the γ-dependence. To identify the stability of this equilibrium solution–and to identify the rates of convergence of
solutions to equilibria under the linearized model later on–we consider the linearization of the system around this
generic equilibrium solution, represented by the (M +1)× (M +1) matrix LS (LS = (sij)1≤i,j≤M+1), with component
sij given by 

−
(
2γ
Ω
)
− (p(N∗) + µ(N∗)), if i = j = 1
−
(
γ
Ω
)
+ 2µ(N∗), if i = 1, j = 2
−
(
γ
Ω
)
, if i = 1; 3 ≤ j ≤M
−
(
γ
Ω
)
− i(p(N∗) + µ(N∗)), if i = j; 2 ≤ j ≤M − 1
−
(
γ
Ω
)
+ ip(N∗), if i = j + 1; 1 ≤ j ≤M − 1
−M(p(N∗) + µ(N∗)), if i = j = M
(i + 1)µ(N∗), if i = j − 1, 2 ≤ j ≤M
p′(N∗)[(j − 1)c∗j−1 − jc
∗
j ] + µ
′(N∗)[(j + 1)c∗j+1 − jc
∗
j ], if i = M + 1; 1 ≤ j ≤M − 1
p′(N∗)(M − 1)c∗M−1 − µ
′(N∗)Mc∗M , if i = M + 1; j = M
p′(N∗)N∗ + p(N∗)− µ′(N∗)N∗ − µ(N∗), if i = j = M + 1
0, otherwise.


(14)
For clarity, an example of the matrix LS with M = 4 is
LS =


− 2γΩ − (p(N
∗) + µ(N∗)) − γΩ + 2µ(N
∗) − γΩ −
γ
Ω −p
′(N∗)c∗1
γ
Ω + p(N
∗) − γΩ − 2(p(N
∗) + µ(N∗)) 3µ(N∗) 0 p′(N∗)[c∗1 − 2c
∗
2] + µ
′(N∗)[3c∗3 − 2c
∗
2]
0 γΩ + 2p(N
∗) − γΩ − 3(p(N
∗) + µ(N∗)) 4µ(N∗) p′(N∗)[2c∗2 − 3c
∗
3] + µ
′(N∗)[4c∗4 − 3c
∗
3]
0 0 γΩ + 3p(N
∗) −4µ(N∗) 3p′(N∗)c∗3 − 4µ(N
∗)c∗4
0 0 0 0 p′(N∗)N∗ + p(N∗)− µ′(N∗)N∗ − µ(N∗)


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We now apply a simplifying assumption to the matrix LS to analytically compute its eigenvalues more easily. In
general, γΩ ∼ 10
−8 − 10−6, and p(N∗), µ(N∗) ∼ 10−1 (when rates are measured in units of year−1), thus, we assume
γ
Ω ≪ p(N
∗), µ(N∗) and define a new matrix LS˜ which is LS but with
γ
Ω = 0 only in elements in which it appears
explicitly. LS˜ is defined by Eq. 14 with γ/Ω in the first five terms set to zero, but with N
∗ determined under the
appropriate general immigration rate γ ≥ 0.
Numerical computation confirms that the eigenvalues of the new matrix LS˜ are essentially identical to those of
the original matrix LS(
γ
Ω ≪ 1), validating our assumption that the term
γ
Ω may be neglected in LS . Note that this
assumption does not cause us to omit the constant γ from the linearization matrix LS entirely, as the steady state
values N∗, c∗k depend on γ. Denote by λ
S
k for k = 1, 2, · · · ,M + 1 the eigenvalues of LS˜ , and note that that the entry
s˜(M+1,M+1) =
dN
dt |N=N∗ = p
′(N∗)N∗ + p(N∗) − µ′(N∗)N∗ − µ(N∗) is an eigenvalue. We denote this eigenvalue by
λSM+1. Since N
∗ is the stable equilibrium solution of Eq. 1, we assume that λSM+1 < 0. The eigenvalues of LS˜ all
have strictly negative real part, as do those of LS. The eigenvalues of the (M + 1) × (M + 1) minor of LS can be
approximated by λ˜Sk = k(p(N
∗)− µ(N∗)), with corresponding eigenvectors y˜k shown in the following Proposition:
Proposition 1. If p(N∗) − µ(N∗) < 0, the eigenvalues {λSk }k=1,...,M of the matrix LS˜ are well approximated by the
terms λ˜Sk = k(p(N
∗)− µ(N∗)), in the sense that there exist vectors y˜k such that ||(LS˜ − λ˜
S
k I)y˜k|| −→ 0 as M −→∞.
Proof. We begin by assuming that the terms λ˜Sk = k(p(N
∗) − µ(N∗)) are themselves eigenvalues of LS˜ , and search
for their corresponding eigenvectors, y˜k = (y˜
1
k, y˜
2
k, · · · , y˜
M
k , 0). Choosing y˜
1
k = 1, we then choose y˜
i
k for i = 2, . . . ,M
inductively so as to force the i-th component of the residual vector, which we denote by [(LS˜−λ˜
S
k I)y˜k]i, to equal zero for
i = 1, 2, · · · ,M − 1. We then verify that [(LS˜− λ˜
S
k I)y˜k]M −→ 0 as M −→∞, so that for M ≫ 1, ||(LS˜− λ˜
S
k I)y˜k|| ≈ 0,
where || · || is any p-norm. (Trivially, [(LS˜ − λ˜
S
k I)y˜k]M+1 = 0.) We first note that the components y˜
1
k, · · · , y˜
M
k of the
approximate eigenvector y˜k corresponding to eigenvalue λ˜
S
k are defined by the recurrence relation,
iy˜ik =
[
(i+ (k − 1))
(
p(N∗)
µ(N∗)
)
+ (i− (k + 1))
]
y˜i−1k − [i− 2]
(
p(N∗)
µ(N∗)
)
y˜i−2k . (15)
The solution of this recurrence relation is then
y˜ik =
k∑
n=1
[∏n−1
j=1 (i− j)
] [∏k−n
j=1 (i+ j)
]
k(−1)n−1(n− 1)!(k − n)!
(
p(N∗)
µ(N∗)
)i−n
, (16)
where we let
∏0
j=1(i ± j) = 1, whenever such a term appears in the above sum. (This is verified in Appendix A.) As
previously mentioned, [(LS˜ − λ˜
S
k I)y˜k]i = 0 for i = 1, 2, · · · ,M − 1. We now compute [(LS˜ − λ˜
S
k I)y˜k]M , obtaining
[(LS˜ − λ˜
S
k I)y˜k]M = (M − 1)p(N
∗)y˜M−1k −Mµ(N
∗)y˜Mk
= p(N∗)
k∑
n=1
[∏n−1
j=0 (M − 1− j)
] [∏k−n
j=1 (M − 1 + j)
]
k(−1)n−1(n− 1)!(k − n)!
(
p(N∗)
µ(N∗)
)M−1−n
− µ(N∗)
k∑
n=1
[∏n−1
j=0 (M − j)
] [∏k−n
j=1 (M + j)
]
k(−1)n−1(n− 1)!(k − n)!
(
p(N∗)
µ(N∗)
)M−n
. (17)
Each term in the sum above has the form pk(M)a
M , where pk(M) is a polynomial of degree k in the variable M , and
a = p(N∗)/µ(N∗). Recalling that p(N∗)/µ(N∗) < 1, then limM−→∞ pk(M)a
M = 0, so that at large values of M ,
[(LS˜ − λ˜
S
k I)y˜k]M ≈ 0. This demonstrates that λ˜
S
k may be regarded as an approximation to the true eigenvalue λ
S
k ,
assuming that the eigenvalues of LS˜ are stable under small perturbations.
The solutions y˜ik, as functions of i for fixed k, are characterized by patterns of oscillatory behavior, as shown in
Fig. 1, which depicts numerical solutions of true and approximate eigenvalues and eigenvectors of LS˜. We choose
p(N∗) and µ(N∗) to satisfy p(N∗) < µ(N∗), so that at homeostatic population levels, the death rate exceeds the
proliferation rate, preventing exponential growth of the population.
Fig. 1(a) presents a sample plot of the eigenvalue spectrum λSk in the case M = 500; on the spectral curve, several
eigenvalues are marked, for which the first 100 components of the corresponding eigenvectors are plotted Fig. 1(b).
As discussed previously, all eigenvalues are negative. The eigenvector plots in Fig. 1(b) indicate that as k increases,
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Figure 1: Eigenvalues and eigenvectors of LS˜, γ > 0. Here, and in all subsequent evaluations, we parameterize our
model using values qualitatively in a range based on human data, where the unit of rates are expressed in 1/year [55–57].
However, the model can have arbitrary units for general cases. (a) Numerically computed eigenvalue spectrum of the
matrix LS˜, with p(N
∗) = 0.12, µ(N∗) = 0.17, and M = 500. Dots identify the locations of the eigenvalues λS1 (red),
λS100 (blue), λ
S
200 (black). (b) First 100 components (y˜
1
k, · · · , y˜
100
k ) of the eigenvectors with indices k = 1, 100, 200, the
eigenvalues corresponding to which are marked on the spectral curve in (a). (c) Comparison of true eigenvalues (λSk )
and approximate eigenvalues (λ˜Sk ) for k = 1, · · · , 100. Approximation is strong for k . 50. (d) (top) Comparison of
y˜j50 and y
j
50 for j = 1, · · · , 40, showing that the approximation is strong. (bottom) Comparison of y˜
j
200 and y
j
200 for
j = 1, · · · , 100, showing that the accuracy of the approximation breaks down, but the qualitative behavior of yj200 is
captured in y˜j200.
the oscillatory “mass” of the corresponding eigenvectors occurs at increasingly large values of j. Fig. 1(c) presents a
comparison of the true eigenvalue spectrum (λSk ) and the approximate eigenvalue spectrum (λ˜
S
k ) of the matrix LS˜ .
The eigenvalue approximation is very strong for 1 . k . M/10, and this remains true as M varies. The quantities
λ˜Sk = k(p(N
∗) − µ(N∗)) over-approximate the λSk for k & M/10. Fig. 1(d) depicts a comparison of yk and y˜k for two
values of k, one below the crossover ∼ M/10 (k = 50, top) and one above M/10 (k = 200, bottom). As expected,
the eigenvector approximation is accurate precisely when the corresponding eigenvalue approximation is accurate.
Even for k & M/10, the approximate eigenvectors y˜k present an appearance similar to that of the y˜k for smaller k.
The diminished accuracy of the eigenvalue/eigenvector pairs at higher k (for fixed M) is attributable to the slower
convergence of [(LS˜ − λ˜
S
k I)y˜k]M to 0 as M →∞ for larger k, which is immediately apparent from the form in Eq. 17.
For a system of a fixed dimension M , increasing µ(N∗) relative to p(N∗) causes the approximate eigenvalues λ˜Sk to
become increasingly valid at larger k, clearly due to the quicker convergence of the residual quantity ||(LS˜ − λ˜
S
k I)y˜k||
to 0 when p(N∗)/µ(N∗)≪ 1, as indicated by Eq. 16.
Increases to µ(N∗) relative to p(N∗) also cause an intensified dampening of the oscillations in the eigenvector y˜k at
lower components j, which creates the illusion of the oscillatory mass shifting to the left as µ(N∗) increases for fixed
p(N∗), as in Fig. 2(b). At the same time, the entire eigenvalue spectrum becomes more negative as µ(N∗) increases,
as indicated in Fig. 2(a), so that increases to the death rate at homeostatic levels indicate much faster convergence to
equilibrium of all ck compartments.
3.3 Behavior of the Linearized and Fully Nonlinear Systems
This section addresses the convergence behavior of solutions in the presence of a positive thymic export rate γ > 0.
This situation represents a functioning thymus, with the possibility for many different levels of functionality, ranging
from total health (high γ ∼ γ0) to dramatically diminished functionality (low γ). It could also represent a new thymic
export rate after transplant of thymic tissue, as studied in the context of DiGeorge’s syndrome in Ciupe et al. [40].
In this case, we determined that for each equilibrium solution of Eq. 1, the system has an equilibrium solution given
by Eqs. 12, 13. If the steady state solution N∗(γ) > 0 of Eq. 1 represents a stable fixed point, the corresponding
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Figure 2: Eigenvalues and eigenvectors of LS˜, γ > 0, varying µ. (a) Numerically computed eigenvalues, λ
S
k ,
for k = 1, · · · , 100, when µ(N∗) = 0.16 and µ(N∗) = 0.6. In both cases, p(N∗) = 0.15, M = 100. (b) Numerically
computed eigenvectors y81.
equilibrium c∗k(γ) will also be stable (typical regulated forms of proliferation and death, p(N) and µ(N), tend to
result in one positive stable equilibrium solution in Eq. 1). If for some i, γi > 0, the solution {c
i
k(t)}
M
k=1, N
i(t)
satisfies cik(t) → c
∗
k(γi), N
i(t) → N∗(γi). The convergence of the total population N
i(t) → N∗ occurs at rate
p′(N∗)N∗ + p(N∗)− µ′(N∗)N∗ − µ(N∗). Based on the eigenvalues and eigenvectors of the approximate linearization,
LS˜ , of Eqs. 1-4 around this equilibrium, we can formally construct approximations to the time-dependent solutions
for ck(t).
In the fully nonlinear system, however, the linearized eigenvalues provide only a priori rates of convergence of
solution trajectories initialized near equilibrium. The accuracy of the eigenvalues in providing convergence rates of
solutions depends on the initial conditions. If the initial conditions, cik(ti), N
i(ti), satisfy c
i
k(ti) ∼ c
∗
k(γi), N
i(ti) ∼
N∗(γi), then the solutions begin near the stable equilibrium, and the eigenvalues provide accurate rates of convergence.
If the initial conditions are far from equilibrium, the eigenvalues may not provide accurate rates of convergence of
the entire solution trajectory. When trajectories are far from equilibrium at time ti, further information about the
speed of convergence can be discerned from the relationship between p(N∗(ti))−µ(N
∗(ti)) and p(N
∗(γi))−µ(N
∗(γi)),
the disparity in proliferation and death rates at the starting and terminal population levels. If these quantities differ
significantly, solution trajectories are generally characterized by a transient period of fast convergence, which carries
the trajectory close enough to the stable equilibrium that convergence rates from then on are those of the linearized
eigenvalues. For example, assume that an abrupt drop in thymic productivity occurs at ti, so that γi < γi−1. As
the steady-state naive T cell population evolves from N∗(γi−1) to N
∗(γi), for which 0 > p(N
∗(γi)) − µ(N
∗(γi)) >
p(N∗(γi−1))−µ(N
∗(γi−1)), the T cell pool will experience a brief period of higher cellular death. As N(t) approaches
N∗(γi), the convergence rates correspond to the eigenvalues found from the linearized approximation.
4 Analysis for γ = 0 (full thymic cessation)
We now proceed to study the system after thymic export is shut off (γ = 0). As in section 3 above, we compute
equilibrium solutions of the truncated system (finite M) that arise when γ = 0, and identify the rates of convergence
of the different ck(t) to equilibrium under the linearized model. We also take M →∞ and consider explicit solutions
of the infinite-dimensional system.
4.1 Analytic Solutions
In the γ = 0 case, the solution for ck(t) for M →∞ can be readily expressed using the method of characteristics. By
using the generating function Q(q, t) defined in Eq. 11 and taking the k-th order derivative of Q with respect to q at
q = 0, we find
ck(t) =
[
B(t)
A(t) +B(t)
]k ∞∑
i=0
ci(0)
i∑
j=0
(
i
j
)(
k + j − 1
k
)(
1−
1
B(t)
)i−j (
A(t)
B(t) (A(t) +B(t))
)j
(18)
and N(t) = A−1(t)
∑∞
k=0 kck(0). Note that for depleted initial conditions c0(0) = Ω and ck(0) = 0 for k ≥ 1, Eq. 18
leads to c0(t) = Ω and ck(t) = 0 for k ≥ 1 at all times. Indeed, the T cell pool is expected to remain empty since there
is no thymic export.
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Fig 3(a) depicts a numerical computation of the solution, ck, of the infinite-dimensional formulation, obtained from
the generating function. We include values of ck for k = 1, 2, · · · , 50 at times t = 30, 60, 90. As a function of k, the ck
present as linear on a logarithmic scale, as expected. To compare the infinite dimensional system with the truncated
system, we also compute solutions, yk, of the truncated Eqs. 2–4 (not pictured). Fig. 3(b) depicts the relative error,
|ck − yk|/ck. As we see, the error is several orders of magnitude smaller than ck, yk themselves at each of the times
t = 30, 60, 90, indicating that the numerical solution of the truncated system Eqs. 2-4 is accurately described by the
exact method-of-characteristics solution and that the infinite- and finite- dimensional systems may be used more or
less interchangeably.
Figure 3: Computation of ck from method of characteristics, comparison with truncated system. (a) Plots
of ck for k = 1, 2, · · · , 50, at times t = 30, 60, 90. Solutions ck were computed numerically from the analytic method
described in 4.1, based on the infinite-dimensional system. As a function of k, ck presents as linear on a logarithmic
scale. (b) Relative error, |ck − yk|/ck for k = 1, 2, · · · , 50, at times t = 30, 60, 90, where ck denotes the solutions
depicted in (a), and yk denotes the numerically computed solutions of the truncated system in Eqs. 2, 3, 4. From
(b), the disparity between the solutions of the infinite dimensional systems (ck) and the finite dimensional truncated
systems (yk) is negligible, validating our decision to use them interchangeably. Coefficient functions: p(N) = p0 > 0,
µ(N) = µ0 + µ1(N
2/(N2 +K2)). Parameter values: p0 = 0.18, µ0 = 0.17, µ1 = 0.04, K = 10
10, Ω = 1016, M = 100.
Initial condition: c0(0) = 10
16 − 1010, c1(0) = 10
10, ck(0) = 0 for k ≥ 2.
4.2 Equilibrium Solutions and Linearization
We now investigate the solution to ck(t) near the fixed points that arise when we take γ = 0 in Eqs. 1-4. In this
case, the system has two possible equilibrium solutions. Denoting generic equilibrium solutions by {c∗k}
M
k=1 and N
∗,
the unstable solution is c∗k = 0 for all k ≥ 1 and N
∗ = 0, and the asymptotically stable solution is c∗k = 0 for all
1 ≤ k ≤ M . However, in the stable state we define N∗ = N˜ > 0, where N˜ satisfies p(N˜) = µ(N˜). To verify the
stability of these solutions, we consider the linearization of the system around this equilibrium, which is represented
by the (M + 1)× (M + 1) matrix we call LU (LU = (uij)1≤i,j≤M+1). The components uij of LU are given explicitly
by:


−j(p(N∗) + µ(N∗)), if i = j ≤M − 1
−Mµ(N∗), if i = j =M
jµ(N∗), if i = j − 1; 2 ≤ j ≤M
jp(N∗), if i = j + 1; 1 ≤ j ≤M − 1
p′(N∗)N∗ + p(N∗)− µ′(N∗)N∗ − µ(N∗), if i = j =M + 1
0. otherwise


(19)
As before, u(M+1),(M+1) = p
′(N∗)N∗ + p(N∗) − µ′(N∗)N∗ − µ(N∗) is an eigenvalue with eigenvector (0, . . . , 0, 1),
and the remaining eigenvalues are those of the (M + 1) × (M + 1) minor of LU . As before, all eigenvalues of the
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(M + 1)× (M + 1) minor have negative real part, and the stability of an equilibrium solution depends on the sign of
u(M+1),(M+1). If N
∗ = 0, then u(M+1),(M+1) = p(0)− µ(0) > 0, as described previously, and the equilibrium c
∗
k = 0,
N∗ = 0 is unstable. On the other hand, if N∗ = N˜ with p(N˜) = µ(N˜), then N∗ represents a positive, homeostatic
cell count, and u(M+1),(M+1) = (p
′(N∗)− µ′(N∗))N∗ < 0, as p(N), µ(N) are assumed to be non-increasing and
non-decreasing, respectively. Therefore, we have that c∗k = 0 and N
∗ = N˜ > 0 is a stable equilibrium solution.
If γ = 0, the solution {ck(t)}
M
k=1, N(t), will evolve away from the unstable equilibrium c
∗
k = 0, N
∗ = 0 and towards
the equilibrium c∗k = 0, N
∗ = N˜ > 0. In this instance, the pool of low-population clones is eradicated due to lack of
thymic productivity, and the high lymphopenic proliferation rate pushes existent clones past the truncation threshold
M , where they are no longer accounted for in ck but are accounted for in N , causing N(t)→ N
∗ despite the fact that
ck(t)→ 0 for all k. As before, we wish to explore further the rates at which individual functions ck diverge from the
unstable fixed point towards the stable one under the linearized and fully nonlinear models. To this end, we study the
eigenvalues of the linearization matrix, LU , evaluated at the two equilibria.
First, consider the eigenvalues of LU evaluated at the unstable equilibrium. In this case, we assume p(0) > µ(0), as
described earlier. Without thymic export, new clones are not generated in the periphery, and existent clones expand
due to the high proliferation rate. Under the dynamics described by Eqs. 2, 3, 4, clones quickly expand beyond
the small-k compartments and get “caught” at the boundary at size M , before depleting due to the slow death-
induced passage of single cell clones through the boundary at k = 1. According to Eq. 1, the total cell population
reaches a natural homeostatic level through peripheral maintenance alone. To investigate the rates at which these
processes occur under the linearized model, we derive approximations to the dominant eigenvalues of LU . Under
the assumption that p(0) > µ(0), we denote the true eigenvalues of LU by λ
U
k for k = 0, 1, · · ·M , with corresponding
eigenvectors zk = (z
M
k , z
M−1
k , · · · , z
1
k, z
0
k) (note that we have reversed the index ordering here). Assign to the eigenvalue
u(M+1),(M+1) = p(0) − µ(0) the label λ
M
k , and to its eigenvector (0, . . . , 0, 1) the label zM . What remains is to find
approximations to the other M eigenvalues of LU , which are precisely the eigenvalues of the (M + 1) × (M + 1)
minor. For i = 0, 1, . . . ,M − 1, denote the approximation to the eigenvalue λUk by λ˜
U
k , and the approximation to the
eigenvector zk by z˜k = (z˜
M
k , z˜
M−1
k , · · · , z˜
1
k, 0). We begin by establishing that the eigenvalue of the (M + 1)× (M + 1)
minor with the smallest magnitude, λU0 , is well approximated by λ˜
U
0 = 0.
Proposition 2. The eigenvalue of LU of smallest magnitude, λ
U
0 , is well approximated by λ˜
U
0 = 0, in the sense that
there exists a vector z˜0 = (z˜
M
0 , z˜
M−1
0 , · · · , z˜
2
0 , z˜
1
0 , 0) such that ||(LU − λ˜
U
0 I)z˜0|| −→ 0 as M −→∞.
Proof. (Note: The components of z˜0 are written above in “descending” order for notational convenience, as this reflects
the order in which they will be chosen recursively below. The i-th component from the left of z˜0, denoted explicitly by
z˜M−i+10 , still corresponds to the function ci.) We begin by considering the matrix (LU − λ˜
U
0 I) = LU and searching for
an appropriate eigenvector, z˜0. We define z˜
1
0 = 1, and once again choose the components z˜
i
0 inductively via a three-term
recurrence relation so as to force the i-th component of (LU − λ˜
U
0 I)z˜0, which we denote as before by [(LU − λ˜
U
0 I)z˜0]i,
to satisfy [(LU − λ˜
U
0 I)z˜0]i = 0 for i = 2, 3, · · · ,M +1. While [(LU − λ˜
U
0 I)z˜0]1 6= 0, we show that [(LU − λ˜
U
0 I)z˜0]1 −→ 0
as M −→∞, so that z˜0 may be regarded formally as an “approximate” eigenvector corresponding to the approximate
eigenvalue λ˜U0 .
Defining z˜10 = 1 and z˜
2
0 =
Mµ(0)
(M−1)p(0) , we let z˜0 be defined by solutions to the recurrence relation,
z˜i+20 =
(
(M − i)(µ(0) + p(0))
(M − (i+ 1))p(0)
)
z˜i+10 −
(
(M − (i − 1))
M − (i + 1)
)(
µ(0)
p(0)
)
z˜i0, (20)
for i = 1, 2, · · · ,M − 2. It can be directly verified that the solution to this recurrence relation is
z˜i0 =
(
M
M − (i− 1)
)(
µ(0)
p(0)
)i−1
. (21)
By construction of the recurrence relation, [(LU − λ˜
U
0 I)z˜0]i = 0 for i = 2, 3, · · · ,M . The first component, [(LU −
λ˜U0 I)z˜0]1, satisfies
[(LU − λ˜
U
0 I)z˜0]1 = −µ(0)M
(
µ(0)
p(0)
)M−1
−→ 0 (22)
as M −→ ∞. Thus, when M ≫ 1, ||(LU − λ˜
U
0 I)z˜0|| ≈ 0, and we may conclude that λ˜
U
0 = 0 and z˜0 are suitable
approximations to λU0 and z0, respectively.
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Recalling that all eigenvalues of LU have negative real parts, the true eigenvalue λ
U
0 has a negative real part of very
small magnitude. We now identify which entries in the eigenvector z0, as approximated by z˜0, are particularly large
in magnitude in comparison with the others. Recalling that the i-th component of z˜0 is given by z˜
i
0 = (M/(M − (i−
1)))(µ(0)/p(0))i−1, the z˜i0 decay nearly exponentially in i, so that ck for large k are preserved by this slow eigenvalue,
in agreement with the described “build up” of clones at the boundary k = M when γ = 0.
The eigenvalue λU1 of second smallest magnitude is well separated from λ
U
0 , and it encodes information about how
the number of small clones evolve. Similar analysis of an eigenvalue λ˜U1 and eigenvector z˜1 approximating λ
U
1 and z1
indicates that ck empties much more rapidly for small k than it does for large k, as small clones expand in size and
race to the boundary at k =M . In particular, all ck except those with k ∼M , which had been preserved by the slow
eigenvalue λU0 , empty at nearly the same rate, λ
U
1 ≈ λ˜
U
1 = (µ(0)− p(0)).
Proposition 3. In the case p(0) > µ(0), the matrix LU has an eigenvalue, λ
U
1 , which is well approximated by
λ˜U1 = (µ(0)− p(0)), in the sense that there exists a vector z˜1 such that ||(LU − λ˜
U
1 I)z˜1|| −→ 0 as M −→∞.
Proof. First define z˜11 = 1, and z˜
2
1 =
(
M+1
M−1
)(
µ(0)
p(0)
)
− 1
M−1 . Then for i = 1, 2, · · · ,M − 2, let z˜
i+2
0 be given by the
solutions to the following recurrence relation:
z˜i+21 = z˜
i+1
1 +
(
M − (i − 1)
M − (i + 1)
)(
µ(0)
p(0)
)(
z˜i+11 − z˜
i
1
)
. (23)
It is worth nothing that if we were to instead choose z˜11 = z˜
2
1 , then the recurrence relation in Eq. 23 would have a
constant solution, z˜i1 = z˜
1
1 for all i = 1, 2, · · · ,M . Although z˜
1
1 6= z˜
2
1 for our purposes, solutions of the recurrence
relation do converge rapidly to constants, as will be discussed later.
By construction, [(LU − λ˜
U
1 I)z˜1]i = 0 for i = 2, 3, · · · ,M + 1. Additionally, [(LU − λ˜
U
1 I)z˜1]1 = 2µ(0)(z˜
M
1 − z˜
M−1
1 ).
To show that [(LU − λ˜
U
1 I)z˜1]1 −→ 0 as M −→ ∞, we use Eq. 23 to derive an explicit bound on the quantity
2µ(0)(z˜M1 − z˜
M−1
1 ). Consider
|z˜i+21 − z˜
i+1
1 | =
(
M − (i− 1)
M − (i+ 1)
)(
µ(0)
p(0)
)
|z˜i+11 − z˜
i
1|
=
(
M − (i− 1)
M − (i+ 1)
)(
M − (i− 2)
M − i
)(
µ(0)
p(0)
)2
|z˜i1 − z˜
i−1
1 |
...
=
(
M − (i− (j − 1))
M − (i + 1)
)(
M − (i− j)
M − i
)(
µ(0)
p(0)
)j
|z˜i+2−j1 − z˜
i+1−j
1 |
...
=
(
M − 1
M − (i+ 1)
)(
M
M − i
)(
µ(0)
p(0)
)i
|z˜21 − z˜
1
1 |. (24)
Taking i = M − 2 in the above relation, we find
|[(LU − λ˜
U
1 I)z˜1]|1 = 2µ(0)|z˜
M
1 − z˜
M−1
1 |
= µ(0) (M(M − 1))
(
µ(0)
p(0)
)M−2
|z˜21 − z˜
1
1 | −→ 0
as M −→ ∞. Thus, for M ≫ 1, ||(LU − λ˜
U
1 I)z˜1|| ≈ 0, and we find that z˜1 is “almost” an eigenvector of LU
corresponding to the approximate eigenvalue λ˜U1 .
We now wish to identify which of the ck empty at the rate determined by the second approximate eigenvalue, λ˜
U
1 .
As it turns out, the eigenvector z˜1 corresponding to this eigenvalue is “nearly” constant, and thus all ck empty at
essentially the same rate. We see this by identifying that even though we are only concerned with a finite number (M)
of terms of the sequence generated by the recurrence relation in Eq. 23, as the index M becomes infinitely large, the
sequence {zi1}
M
i=1 exhibits “Cauchy-like” behavior, mimicking “convergence” to a limiting value. We make this more
precise in the following Proposition:
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Proposition 4. Let z˜1 be an approximate eigenvector of LU corresponding to approximate eigenvalue λ˜
U
1 , where z˜1 is
generated by the recurrence relation in Eq. 23. Then at large M , the components of z˜1 exhibit “Cauchy-like” behavior:
for any ε > 0 and 0 < c < 1, we may choose M ∈ N such that |z˜m1 − z˜
n
1 | < ε for all cM ≤ m ≤M and cM ≤ n ≤M .
Proof. Recalling the bound on |z˜i+21 − z˜
i+1
1 | obtained in Eq. 24, we find
|z˜m1 − z˜
n
1 | =
∣∣∣∣∣
m−1∑
i=n
(
z˜i+11 − z˜
i
1
)∣∣∣∣∣ ≤
m−1∑
i=n
|z˜i+11 − z˜
i
1|
=
m−1∑
i=n
(
M − 1
M − i
)(
M
M − (i − 1)
)(
µ(0)
p(0)
)i−1
|z˜21 − z˜
1
1 |
≤M(M − 1)|z˜21 − z˜
1
1 |
m−1∑
i=n
(
µ(0)
p(0)
)i−1
= M(M − 1)|z˜21 − z˜
1
1 |
(
µ(0)
p(0)
)n−1m−n−1∑
j=0
(
µ(0)
p(0)
)j
= M(M − 1)|z˜21 − z˜
1
1 |
(
µ(0)
p(0)
)n−11−
(
µ(0)
p(0)
)m−n
1− µ(0)
p(0)


≤
|z˜21 − z˜
1
1 |(
1− µ(0)
p(0)
)M(M − 1)(µ(0)
p(0)
)n−1
≤
|z˜21 − z˜
1
1 |(
1− µ(0)
p(0)
)
[
M(M − 1)
(
µ(0)
p(0)
)cM−1]
.
Recalling that M(M − 1)
(
µ(0)
p(0)
)cM
−→ 0 as M −→∞, we may choose M large enough such that
M(M − 1)
(
µ(0)
p(0)
)cM
≤ ε
[
1−
(
µ(0)
p(0)
)](
µ(0)
p(0)
)
|z˜21 − z˜
1
1 |
, (25)
allowing us to conclude that |z˜m1 − z˜
n
1 | < ε for all M ≥ m,n ≥ cM .
By taking 0 < c, ε ≪ 1, we find that “most” components of z˜1 are within an ε-distance of each other, so that the
eigenvector is nearly constant. (The constancy breaks down at the components representing large-k compartments.)
With this, we are able to classify the rates at which all of the ck are lost from the pool. As the eigenvector corresponding
to the second smallest magnitude eigenvalue, λU1 ≈ λ˜
U
1 , is nearly constant, all ck, except those with k ∼M , empty at
nearly the same rate, on a time scale ∼ |µ(0)− p(0)|−1.
The remaining eigenvalues λU2 , · · · , λ
U
M−1 are not treated analytically, but numerical computation indicates that a
similar general approximation to the k-th eigenvalue, λ˜Uk , may be made, taking the form λ˜
U
k = k(µ(0)−p(0)). The true
eigenvalues, λUk , are depicted in Fig. 4(a) (Comparison of the true and approximate spectra is omitted, as the result
is similar to that depicted in Fig. 1(c). That is, λUk ≈ k(µ(0)− p(0)) if k . M/10.). The oscillatory behavior observed
in the approximate eigenvectors in the case p(N∗) < µ(N∗) of section 3 is absent here; although the subsequent
approximate eigenvectors z˜2, · · · , z˜M−1 do not share the Cauchy-like behavior of z˜1, the components corresponding to
ck for small k do not vary much in magnitude, and are thus interpreted as being nearly constant themselves (Fig. 4(b).)
Thus, we conclude that for small k, the functions ck all have very similar dynamics, diverging at the rate |µ(0)− p(0)|,
while for large k, the ck converge very slowly, at a rate governed by the dominant, near-zero eigenvalue λ
U
0 .
We now consider the stable equilibrium solution, c∗k≤M = 0 for k ≥ 1, N
∗ = N˜ > 0. In this case, the linearization
around this equilibrium may be expressed as p(N∗)LU ′ , where LU ′ = (u
′
ij)1≤i,j≤M+1 is the (M +1)× (M +1) matrix
with component u′ij given by
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Figure 4: Eigenvalues and eigenvectors of LS˜, γ = 0. (a) Numerically computed eigenvalue spectrum of the matrix
LU , with p(0) = 0.17, µ(0) = 0.12, and M = 500. Dots identify the locations of the eigenvalues λ
U
1 (red), λ
U
6 (blue),
λU21 (black). The inset shows the eigenvalues of the full system, including the positive eigenvalue (when p(0) > µ(0))
and the eigenvalue λU0 ≈ 0. (b) First 30 components (z
500
k , · · · , z
470
k ) of the eigenvectors with indices k = 1, 6, 21, the
eigenvalues corresponding to which are marked on the spectral curve in (a). (Note that the eigenvectors were defined
in a “reverse-order”, so that z500k corresponds to compartment c1, z
495
k to compartment c6, and z
480
k to compartment
c21 (generally: z
M−j+1
k corresponds to compartment cj).


−2j, if i = j ≤M − 1
−M, if i = j = M
j, if i = j − 1; 2 ≤ j ≤M
j, if i = j + 1; 1 ≤ j ≤M − 1
p′(N∗)N∗+p(N∗)−µ′(N∗)N∗−µ(N∗)
p(N∗) , if i = j = M + 1
0. otherwise


(26)
For reference, an example of the matrix LU ′ , with M = 4, is given below:

−2 2 0 0 0
1 −4 3 0 0
0 2 −6 4 0
0 0 3 −4 0
0 0 0 0 p
′(N∗)N∗+p(N∗)−µ′(N∗)N∗−µ(N∗)
p(N∗)


(27)
Denote by λU
′
k for k = 1, 2, · · · ,M,M+1 the eigenvalues of the matrix LU ′ evaluated at the stable equilibrium solu-
tion, and xk = (x
1
k, x
2
k, · · · , x
M
k , x
M+1
k ) their corresponding eigenvectors. As before, let λ
U ′
M+1 =
1
p(N∗)
∂[(p−µ)N ]
∂N
|N=N∗ <
0. Then, the remaining eigenvalues λU
′
1 , · · · , λ
U ′
M are those of the (M + 1) × (M + 1) minor of LU ′ , which are inde-
pendent of the parameters of the system except M . (Of course, the eigenvalues of p(N∗)LU ′ are then p(N
∗)λU
′
k for
k = 1, · · · ,M+1.) These eigenvalues and eigenvectors are not treated analytically. The analysis conducted in section 3
does not apply, as it relied on the assumption p(N∗) < µ(N∗), which no longer holds. However, numerical computation
indicates that in the case p(N∗) = µ(N∗), which applies here, the eigenvalue spectrum and associated eigenvectors
qualitatively resemble the λSk , yk studied analytically in section 3.
4.3 Behavior of the Linearized and Fully Nonlinear Systems
We now interpret these results in the context of the particular diseased states to which they naturally apply. We first
identified an unstable equilibrium solution, c∗k = 0, N
∗ = 0, and studied the linearization of the system around this
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equilibrium. Under the linearized model, if γi = 0 for some i, the eigenvalue/eigenvectors pairs suggest that solutions
diverge away from this equilibrium, with cik for small k evolving at a rate ∼ λ
U
1 = (µ(0) − p(0)), and c
i
k for k ∼ M
evolving at the very slow rate given by the small-magnitude eigenvalue, λU0 . The total population N
i(t) evolves at
the rate (p(0)− µ(0)). This situation represents the repopulation of the T cell pool from a small number of cells via
peripheral proliferation within a highly pathological state involving both complete thymic inactivity (e.g. thymectomy
or total functional cessation) and near full lymphopenia (as may result from treatment regimens for cancer, etc.).
We then identified a stable equilibrium solution, c∗k = 0, N
∗ = N˜ > 0. As N˜ is asymptotically stable, N i(t)→ N˜
after diverging from N∗ = 0. Under the linearized model, the eigenvalue/eigenvector pairs suggest that cik(t) → 0
slowly for small k, and cik(t)→ 0 much more quickly for large k.
As before, the validity of the eigenvalues in providing accurate convergence rates of cik, N
i to and from equilibria
depends on the initial condition cik(ti) in the full nonlinear model. If the human is in a state of immune health for
t < ti, so that γi−1 > 0 and the initial conditions c
i
k(ti), N
i(ti) > 0 satisfy c
i
k(ti) ∼ c
∗
k(γi−1), N
i(ti) ∼ N
∗(γi−1), we
expect that p(N i(ti)) < µ(N
i(ti)). The higher rate of death than proliferation at ti may cause a transient period of
quick collapse, with N i(t) decreasing to N˜ . As N i(t)→ N˜ , convergence occurs at the rates dictated by the linearized
eigenvalues. If γi−1 > 0 but c
i
k(ti), N
i(ti) ∼ 0, so that the thymus is functioning to some extent but the T cell pool
has been eradicated, trajectories first diverge away from the unstable zero equilibrium at rates given by the linearized
eigenvalues. As p(N i(ti)) − µ(N
i(ti))→ p(N˜) − µ(N˜) = 0, the motion of trajectories transitions from being dictated
by the eigenvalues of the unstable equilibrium to those of the stable equilibrium.
In summary, we show in Proposition 2 that ck of larger k is sustained by a near-zero eigenvalue λ
U
0 ≃ 0, as the
solution evolves away from the unstable empty state when γ = 0. Furthermore, in Propositions 3 and 4 we identify a
series of negative eigenvalues, and a uniform eigenvector corresponding to the slowest decay rate λU1 < 0. It suggests
a uniform asymptotic decay of components other than the larger k components preserved by λU0 .
5 Special Cases and Numerical Evaluation
Using the approximate rates of convergence provided by linearization, we can now study the time scale of the T cell
pool’s adjustment to a new export rate. While some T cell clones will expand and attain a large size, most are small.
Thus, in both the cases of thymic atrophy and recovery, we take as a proxy for the rate at which the T cell diversity
converges to equilibrium the eigenvalue that dictates the rate of convergence of c1, typically given by the quantity
p(N∗) − µ(N∗) (this tends to also be the dominant eigenvalue). Recalling that p(N∗) < µ(N∗), high proliferation
rates (p(N∗) ∼ µ(N∗)) lead to small values of |p(N∗) − µ(N∗)|, thus slower adjustment of diversity to the changing
γ. That is, in a proliferation-dominant scenario, a drop in thymic export leads to repopulation via clonal expansion.
In this section, we study several specific models arising from canonical choices of p and µ, and compute the changing
convergence rate as gamma varies.
5.1 The Logistic Model: regulated proliferation, constant death
We begin with the canonical logistic growth model, taking p(N) = p0(1 − N/K), µ(N) = µ0, where p0, µ0 > 0 are
basal rates of cellular proliferation and death, respectively, and K > 0 is an inherent carrying capacity. Under this
model, Eq. 1 has a positive steady state, N∗, given by
N∗ =
(
K
2p0
)(
(p0 − µ0) +
√
(p0 − µ0)2 +
4γp0
K
)
. (28)
In this case, p(N∗) − µ(N∗) = p0
(
1− N
∗
K
)
− µ0 =
1
2
(
(p0 − µ0)−
√
(p0 − µ0)2 +
4γp0
K
)
< 0, so that the assumption
p(N∗) < µ(N∗) always applies. Moreover, λ˜SM+1 = −
√
(p0 − µ0)2 +
4γp0
K
, so it is clear that 0 > λ˜S1 > λ˜
S
M+1, and λ˜
S
1
is the dominant eigenvalue. Then,
|p(N∗)− µ(N∗)| =
1
2
(
−(p0 − µ0) +
√
(p0 − µ0)2 +
4γp0
K
)
. (29)
In Fig. 5, the quantity λ˜S1 is plotted against γ for several different combinations of p0, µ0, showing the unboundedness
of the convergence rate as γ increases. Within this physiological range of γ values, the dependence of λ˜S1 on γ presents
as linear on a log-log plot, indicating a power law relationship. Indeed, the power law is described in detail in the
caption of Fig. 5.
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Figure 5: Dominant eigenvalue, λ˜S1 , of LS˜, plotted against γ, Case 1. In (a), p0 = 0.18, µ0 = 0.17. In (b),
p0 = 0.018, µ0 = 0.017. In (c), p0 = 0.0018, µ0 = 0.0017. There is an approximate power law relationship between
λ˜S1 and γ within this range of parameter values. In (a), for example, the best fit line to the curve K = 10
7 is given
by log(λ˜S1 ) = (2.673 × 10
−11) log(γ) + 5.594, with R2 = 0.8904. The curve K = 109 is fitted by log(λ˜S1 ) = (2.672 ×
10−12) log(γ)+0.558, with R2 = 0.8905, and the curve K = 1011 is fitted by log(λ˜S1 ) = (2.67×10
−13) log(γ)+0.05478,
with R2 = 0.8911.
5.2 Constant Proliferation, Regulated Death
Let us now assume that p(N) = p0 > 0 and µ(N) = µ0 +
µ1N
2
K2+N2 , with µ0, µ1 > 0, in the determination of N(t) via
Eq. 1. We assume that p0 > µ0 and p0− (µ0+µ1) < 0, so that the action of the proliferation-death mechanism results
in net cellular birth at low cell counts and net cellular death at high cell counts. The steady states of Eq. 1 are given
by the roots of the following cubic
P (N) = (p0 − (µ0 + µ1))N
3 + γ0N
2 + (p0 − µ0)K
2N + γK2. (30)
First note that P (0) = γK2 > 0, and the highest order coefficient satisfies (p0 − (µ0 + µ1)) < 0 by assumption, so
that P (N) −→ −∞ as N −→ ∞, and P (N) has at least one positive, real root. From Descartes’ rules of signs, the
polynomial has at most one positive real root, so we may conclude that it has precisely one positive real root. This root
corresponds to the only physically relevant stable fixed point of dNdt . By regarding this root, N
∗, as the intersection of
the line γ + (p0 − µ0)N and the rational expression µ1
(
N3
K2+N2
)
, we see that N∗ →∞ as γ → 0.
γ
101 105 109 1013
λ˜
S 1
10-10
10-7
10-4
10-1 (a)
K = 107
K = 109
K = 1011
γ
101 105 109 1013
(b)
γ
101 105 109 1013
(c)
Figure 6: Dominant eigenvalue, λ˜S1 , of LS˜, plotted against γ, Case 2. In (a), p0 = 0.18, µ0 = 0.17, and
µ1 = 0.004. In (b), p0 = 0.018, µ0 = 0.017, and µ1 = 0.004. In (c), p0 = 0.0018, µ0 = 0.0017, and µ1 = 0.0004.
The relationship between λ˜S1 and γ follows a power law for low values of γ, before reaching a plateau for high values
of γ. In (a), the best fit line to the curve K = 107 over the power law region (∼ γ ∈ [101, 2.2 × 104]) is given by
log(λ˜S1 ) = (1.492 × 10
−7) log(γ) + 1.972 × 10−5, with R2 = 0.9979. The curve K = 109 over the power law region
(∼ γ ∈ [101, 2.1 × 106]) is fitted by log(λ˜S1 ) = (1.505 × 10
−9) log(γ) + 1.039 × 10−5, with R2 = 0.998, and the curve
K = 1011 over the power law region (∼ γ ∈ [101, 2.2× 108]) is fitted by log(λ˜S1 ) = (1.502× 10
−11) log(γ) + 7.6× 10−6,
with R2 = 0.998.
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We also verify that the eigenvalues λ˜S1 , λ˜
S
M+1 satisfy 0 > λ˜
S
1 > λ˜
S
M+1, so that λ˜
S
1 is, in fact, the dominant eigenvalue.
We first check that 0 > λ˜S1 . Recalling that λ˜
S
1 = p(N
∗) − µ(N∗) = p0 −
(
µ0 + µ1
(
(N∗)2
(K2+(N∗)2)
))
, we see after some
simple algebraic manipulation that the condition λ˜S1 < 0 is equivalent to
N∗ >
(
(p0 − µ0)K
2
|p0 − (µ0 + µ1)|
) 1
2
:= N. (31)
But P (N) = γ(p0−µ0)K
2
|p0−(µ0+µ1)|
+ γK2 > 0. That P (N) > 0 and P (N) −→ −∞ as N −→∞, along with the fact that P (N)
has only one real positive root indicates that N∗ does, in fact, satisfy Cond. 31, so that λ˜S1 < 0. It is easily verified
that −µ′(N∗)N∗ < 0, and consequently that λ˜S1 > λ˜
S
M+1.
From the fact that N∗ →∞ as γ →∞, we have that |p(N∗)− µ(N∗)| → p0 − (µ0 + µ1) as γ →∞. This limiting
behavior is reflected in the eventual plateau seen in Fig. 6, which plots the quantity λ˜S1 in this case. Before the plateau
occurs, γ and λ˜S1 are again related by a power law. The transition from power law to plateau occurs at a “threshold”
value, γ∗, of γ, at which the rate of T cell adjustment becomes sensitive to a changing thymic export rate. If, for some
i, γi−1, γi ≥ γ
∗, λ˜S1 is unaffected by the transition from thymic export rate γi−1 to thymic export rate γi–that is, the
T cell pool adjusts to the new thymic export rate γi as quickly as it had adjusted to the previous thymic export rate
γi−1. If, however, (γi − γ
∗)(γi−1 − γ
∗) < 0, then a dramatic shift in the adjustment rate will occur. Thus, parameter
choices that result in a low threshold value γ∗ might correspond to physiological conditions under which an instance of
acute thymic atrophy actually does not affect T cell adjustment rates. Likewise, a high threshold value of γ∗ indicates
potential sensitivity of adjustment rates to the changing level of thymic export, with adjustment rates obeying a power
law dependence on γ.
6 Discussion and Conclusions
In this paper, we formulated a model of how the naive T cell pool adjusts to changes in the rate of thymic export of new
T cells during a cycle of stress-induced atrophy and recovery, and how it may be reconstituted following an instance
of severe lymphopenia induced by a state of immune disease, or treatments such as chemotherapy. Our underlying
model is a birth-death-immigration process studied under a mean-field approximation for the mean clone abundance
distribution (or clone count) ck(t). A recent investigation into the fully stochastic model indicates that the true ck
differs from the ck derived using the mean-field assumption (Eqs. 2–4 and 5) only for very large k ≈ N [52]. Thus, our
analyses may be inaccurate only if a single large clone dominates the whole population.
Another modeling choice we made is that TCRs are generated one naive T cell at a time. Successive emigrations
from the thymus are uncorrelated with the TCRs that are produced. However, emigration can be clustered, where
there is cell proliferation of a thymocyte generating ∆ ∼ 2 − 4 copies of naive T cells carrying the same TCR during
each emigration event. In this case, we simply modify the immigration terms in Eqs. 2-3. For Eq. 2, the immigration
term proportional to γ/Ω is removed, while the immigration term γ/Ω(ck−1 − ck) is replaced by γ/Ω(ck−∆ − ck) in
Eq. 3. By setting cℓ<0 = 0, the solution to Eqs. 2-3 can be numerically evaluated but a closed-form analytic solution
is not possible. Solutions with clustered immigration (∆ > 1) show no qualitative difference with ∆ = 1, with minor
quantitative differences arising only for very small k.
In Section 3, we found that our mean-field ODE model admitted one stable equilibrium solution when γ > 0.
From an analysis of the eigenvalues and eigenvectors of the system linearized around this stable equilibrium, we found
that for small k, perturbations in ck about a steady-state solution are weighted more strongly in the slowest mode
(slowest eigenvalue) λS1 = p(N
∗) − µ(N∗) < 0. As also shown in Fig. 1, the variation in ck for larger k contains
higher weights of the faster modes corresponding to more negative (faster) eigenvalues λSℓ = ℓ(p(N
∗) − µ(N∗)) < 0.
Similarly, in Section 4, we analyzed the eigenvalue and eigenvector decomposition of the solution for γ = 0, for which
two equilibrium points, N∗ = 0 and N∗ > 0, arise. For p(N∗)−µ(N∗) < 0, we find the same decomposition of ck(t) as
for the γ > 0 case in Section 3. Thus, for relaxation of ck(t) towards a finite steady-state, our eigenvalue/eigenvector
analyses suggests that the counts of large clones might evolve faster towards that of the new steady-state. For the
unstable equilibrium state N∗ = 0, the eigenvalue/eigenvector decomposition of ck is shown in Fig. 4. In this unstable
case, the slowest eigenvalue λU0 ≈ 0 has a corresponding eigenvector z
i
0 with decaying elements with i. This result
predicts that high-population (M − i) clones relax slowly (recall that the labeling is inverted: i = M − 1 corresponds
to the direction of c1).
In addition to decomposing the linearized solutions in terms of eigenvalues and eigenvectors, we explicitly plot tra-
jectories of ck(t) following small, abrupt changes in γ. By plotting the log of the deviation δck = (ck(t)−ck(∞))/ck(∞)
in all cases (Fig. 7(a)), we can see that counts of small clones evolve faster after perturbation. Although this seems to
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Figure 7: Time-dependence of ck(t) near fixed points. (a) The explicit time-evolution of δck = (ck(t) −
ck(∞))/ck(∞) following a small abrupt change γ = 1.8 × 10
10 → 0.99 × 1.8 × 1010 at t = 0. The evolution from
one nonzero steady state to another nonzero steady state shows that clone counts of small clones appear to evolve
faster than counts of larger clones. (b) Similarly, the number of small clones also evolve faster away from an unstable
empty equilibrium state N∗ = 0.
contradict the eigen decomposition of the γ > 0 case, the coefficients and eigenvector elements corresponding to larger
ℓ are negative (see Figs. 1(b) and (d)) which convert fast decaying modes into short bursts of growth and conspire to
cancel the fast dynamics indicated by the more negative eigenvalues. In fact, we see that the clone counts of large
clones actually evolve more slowly than the rate associated with the largest eigenvalue. This behavior can also be
heuristically understood by noticing that under a given change in γ, the immigration term γ(ck−1− ck)/Ω is larger for
smaller k because ck ∼ 1/k. Thus, for a given change in γ, the perturbation is larger for the equations with smaller k
and inducing changes in ck(t) that appear larger.
In section 5, we infer the rate of convergence of the counts of the smallest (but most common) clones to equilibrium
by computing the dominant eigenvalue as a function of γ > 0 for two choices of regulated functions p(N), µ(N). In
section 5.1, we test the logistic model, which assumes a constant death rate but a population-dependent proliferation
rate. From the explicit form of λ˜S1 in Eq. 29, p(N
∗)− µ(N∗)→∞ as γ →∞ for fixed values of the other parameters,
which produces the power-law relationship between γ and λ˜S1 depicted in Fig. 5. In section 5.2, we assumed instead
a constant rate of cellular proliferation with an N -dependent death rate. In this case, which differs from the logistic
formulation in that regulation is incorporated into µ(N) via a Hill-type function, γ and λ˜S1 are related by a power law
for low γ, before reaching a plateau at higher γ.
Since regulation through death is typically associated with the actual mechanism of naive T cell survival, we expect
this mechanism to be more realistic than a population-dependent proliferation rate p(N). Thus, jumps in the thymic
export rate that either cross the threshold value of γ, or occur between two values of γ both in the power-law region,
can be expected to produce changes in both the equilibrium values of ck and also the convergence rates. If a jump in
γ occurs between two values of γ that are both in the plateau region, the equilibrium values shift, but the convergence
rates stay the same. The presence of the power law region indicates the robustness of the T cell diversity during a
time of severe thymic atrophy. That is, the slower convergence of the T cell diversity to equilibrium at low γ values
protects the pool from quick shifts to the lower diversity associated with lower γ values.
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A Verification of recurrence relation solution
Here, we verify that Eq. 16 satisfies the recurrence relation in Eq. 15. For notational simplicity, we assume p/µ ≡
p(N∗)/µ(N∗) is evaluated at the relevant steady state defined by N∗. Inserting Eq. 16 into the right-hand-side of
Eq. 15, we find
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